Weixiang Lian

Weixiang Lian

Auto-generated profile, based on publicly available information

Weixiang Lian

Department of Preventive and Population Medicine, Office of Clinical Epidemiology, Analytics, and Knowledge (OCEAN) Tan Tock Seng Hospital Singapore Singapore

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in npj Vaccines
Verified
Journal Article
Open access
PDF file
SSSapna P. Sadarangani
Sapna P. Sadarangani
BYBarnaby E. Young
Barnaby E. Young
WLWeixiang Lian
Weixiang Lian
HPHwee Pin Phua
Hwee Pin Phua
MCMark I.-C. Chen
Mark I.-C. Chen
ACAngela Chow
Angela Chow
Immunosenescence (age-related immune dysfunction) and inflamm-aging contribute to suboptimal immune responses in older adults to standard-dose influenza vaccines, which may be exacerbated in those with metabolic co-morbidities. We sought to investigate metabolic factors/predictors of influenza vaccine immune response in an older adult (age ≥65 years) cohort in Singapore, where influenza typically circulates year-round. The primary outcome for the DYNAMIC prospective cohort study was haemagglutination-inhibition titer (HAI) response to each of the trivalent inactivated influenza vaccine strains at day 28 (D28) compared to baseline (D0), as assessed by seroconversion and D28/D0 log2 HAI fold rise. Baseline blood samples were tested for total Vitamin D (25-(OH) D) levels. We enrolled 234 participants in June–Dec 2017. Two hundred twenty completed all study visits. The median age was 71 [IQR 68–75] years, 67 (30.5%) had diabetes mellitus (DM), and the median BMI was 24.9 [IQR 22.2–27.8] kg/m2. Median baseline totals 25-(OH) D was 29 [IQR: 21–29] ng/ml. Age, DM, obesity, and baseline 25-(OH) D were not associated with HAI fold rise in multivariable analysis. More recent prior influenza vaccination and higher baseline HAI titers were associated with lower HAI fold rise for influenza A/HK/H3N2. Physical activity was associated with a higher HAI fold rise for influenza A/HK/H3N2 in a dose-response relationship (p-test for trend = 0.015). Older adults with well-controlled metabolic co-morbidities retain HAI response to the influenza vaccine, and physical activity had a beneficial effect on immune response, particularly for influenza A/HK/H3N2.

28 October 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
HHHtet Lin Htun
Htet Lin Htun
WLWeixiang Lian
Weixiang Lian
HPHwee Pin Phua
Hwee Pin Phua
MLMoses Yidong Lim
Moses Yidong Lim
DCDaniel Ek Kwang Chew
Daniel Ek Kwang Chew
WLWei‐Yen Lim
Wei‐Yen Lim
Aims: This study aims to investigate the relationship between long‐term visit‐to‐visit within‐person HbA1c variability and hospitalisation outcomes in adults with type 2 diabetes (T2D). Methods: We conducted a cohort study at a tertiary hospital in Singapore involving people aged 21 to 101 years with T2D who had ≥3 HbA1c tests over 2 years. HbA1c variability was assessed using coefficient of variation (CV), variability independent of the mean (VIM) and HbA1c variability score (HVS). A 1‐year follow‐up was performed after the last HbA1c measurement to identify all‐cause and potentially avoidable hospitalisations (PAH), categorised as overall, acute, chronic and diabetes composites. Results: The study included 14 923 patients (mean age: 62.9 ± 12.9 years; 55% male). The median HbA1c variability was 8.6% CV (IQR: 5.1–14.3). Higher quartiles of HbA1c variability were associated with greater risks of PAH and all‐cause hospitalisations, independent of glycaemic control. Compared to Q1, for example, the risk ratios and 95% confidence intervals for diabetes‐related PAH based on HbA1c CV were as follows: Q2, 1.32 (0.93–1.88); Q3, 1.65 (1.18–2.31) and Q4, 2.16 (1.54–3.03). For all‐cause hospitalisations, they were as follows: Q2, 0.97 (0.90–1.05); Q3, 1.08 (1.00–1.17) and Q4, 1.16 (1.07–1.26). When stratified by glycaemic control, elevated risk of PAH persisted even in those with optimal glycaemic control. Consistent findings were observed using HbA1c VIM and HVS measures. Conclusions: In individuals receiving care at specialist outpatient clinics of a tertiary hospital, HbA1c variability is associated with a higher risk of PAH. Comprehensive diabetes management strategies addressing both glycaemic control and variability may offer benefits.

1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
YSYi Heng Seow
Yi Heng Seow
RWRu Xin Wong
Ru Xin Wong
JLJohn Heng Chi Lim
John Heng Chi Lim
WLWeixiang Lian
Weixiang Lian
YYYoon Sim Yap
Yoon Sim Yap
FWFuh Yong Wong
Fuh Yong Wong
Seow YH, et al. J Breast Cancer. 2019 Mar;22:e16. https://doi.org/10.4048/jbc.2019.22.e16

30 May 2025 in CMI Communications
Verified
Journal Article
Open access
BKBo Yan Khoo
Bo Yan Khoo
PHPei Yun Hon
Pei Yun Hon
JLJanis Loh
Janis Loh
HPHwee Pin Phua
Hwee Pin Phua
WLWeixiang Lian
Weixiang Lian
SVShawn Vasoo
Shawn Vasoo